Loading...
Docoh

MyMD Pharmaceuticals (MYMD)

Utility
Method of treating cocaine addiction
17 May 22
A pharmaceutical composition containing isomyosmine or a pharmaceutically acceptable salt thereof is administered to an individual in need thereof for treating a substance addiction, inclusive of addiction to heroin (diacetylmorphine), cocaine, opioids, methadone, d-methamphetamine, barbiturates, alcohol, benzodiazepines, amphetamines, or buprenorphine.
Jonnie R. Williams
Filed: 11 Nov 19
Utility
Methods of Regulating Oxidoreductase Activity for Treatment of Inflammation and Age-Related Disorders
3 Mar 22
In some aspects, a method of regulating oxidoreductase activity for treating an inflammation or age-related disorder involves administering to an individual isomyosmine or a pharmaceutically acceptable salt thereof.
Jonnie R. Williams
Filed: 11 Nov 21
Utility
Methods of treating sarcopenia
11 Jan 22
In some aspects, a method of regulating oxidoreductase activity for treating an inflammation or age-related disorder involves administering to an individual isomyosmine or a pharmaceutically acceptable salt thereof.
Jonnie R. Williams
Filed: 14 Jul 20
Utility
Synthetic Cannabinoid Compounds for Treatment of Substance Addiction and Other Disorders
9 Dec 21
A method of increasing the cannabinoid levels in a genetically modified Cannabis sativa plant includes genetically modifying the plant to induce the overexpression of the gene that controls the expression of tetrahydrocannabinolic acid (THCA) synthase and/or cannabidiolic acid (CBDA) synthase.
Jonnie R. Williams
Filed: 22 Jul 21
Utility
Methods of reversing normal aging process and extending lifespan
23 Nov 21
In one aspect, a method of altering programmed cell death includes administering to an individual in need thereof a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof.
Jonnie R. Williams
Filed: 12 Nov 19
Utility
Method of treating disorders associated with chronic inflammation
24 Aug 21
In one aspect, a method of treating a disorder associated with chronic inflammation includes administering to an individual in need thereof a therapeutically effective amount of isomyosmine or a pharmaceutically acceptable salt thereof.
Jonnie R. Williams
Filed: 29 Oct 20
Utility
Synthetic cannabinoid compounds for treatment of substance addiction and other disorders
10 Aug 21
A method of increasing the cannabinoid levels in a genetically modified Cannabis sativa plant includes genetically modifying the plant to induce the overexpression of the gene that controls the expression of tetrahydrocannabinolic acid (THCA) synthase and/or cannabidiolic acid (CBDA) synthase.
Jonnie R. Williams
Filed: 11 Feb 19
  • 1
Patents are sorted by USPTO publication date, most recent first